VMPL New Delhi [India], September 21: India's first indigenous CAR-T therapy, NexCAR 19 has moved an advanced form of cancer treatment from the realm of possibility into real-world clinical practice. Physicians treating relapsed and refractory blood cancers now face a new set of decisions - which patients to refer, when, and how safely the therapy can be delivered. Dr. Anusha Swaminathan, Consultant Hemato-
This is a summary. For the full story, refer to the original source. Public of India presents verified citizen-relevant reporting.